Gender Dysphoria clinical trials
17 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- Topical Estrogen: Brief Intervention to Improve Postoperative Experience for Transgender Men Undergoing Hysterectomy
- Development of Effective, Opioid Sparing Techniques for Peri-operative Pain Management of Transgender Patients Undergoing Gender Affirming Surgeries
- Evaluating the Efficacy of Force Modulating Tissue Bridge Device in Preventing Hypertrophic Scars Following Gender-Affirming Mastectomy
- Brain Health in Transgender Adults
- Gender Affirming Vaginoplasty With Tubularized Augmented Peritoneal Cap (TAPCap) Utilizing Fish Skin Xenograft (Kerecis™)
- Puberty, Testosterone, and Brain Development
- The Effect of Sex Steroid Replacement Therapy in the Hypogonadism and Transgender Active-Duty Population
- Prospective Study of Sensation and Satisfaction in Cancer and Transgender Mastectomy Patients
- Pubertal Blockade and Estradiol Effects on Cardiometabolic Health for Transitioning Youth
- Evaluation of Gender-Affirming Treatments on Pulmonary Function in Transgender and Gender Diverse Patients
- The Role of Amnion Membrane Allografts in Nipple Preservation
- Can 3D Modeling Enhance Patient Understanding, Education, and Surgical Outcomes in Gender Affirming Peritoneal Vaginoplasty?
- Novel Delivery Method of Transgender Voice Therapy Using a Mobile Application
- QAIAx (AIhealth4U) - AI Public Health Central: Microcity-A (re Quantum AI Agency Aka AI City Hall Project, UPSTO App Nos. 64/074,526, 64/063,557, 63/903,181, 63/729,428
- Polyethylene-glycol Assisted Nerve Repair in Phalloplasty
- MaPGAS Decision Making
- Effect of Nitropaste in Chest Masculinizing Surgery
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Gender Dysphoria” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.